Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
14.55 USD | +6.28% | +12.41% | -33.13% |
Apr. 25 | Truist Securities Cuts Sage Therapeutics' Price Target to $18 From $22, Hold Rating Maintained | MT |
Apr. 25 | Transcript : Sage Therapeutics, Inc., Q1 2024 Earnings Call, Apr 25, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.13% | 824M | |
-2.56% | 103B | |
+1.78% | 95.28B | |
+1.46% | 22.15B | |
-15.30% | 21.02B | |
-8.58% | 18.15B | |
-41.01% | 16.73B | |
-13.43% | 16.05B | |
+4.29% | 13.68B | |
+35.53% | 12.17B |
- Stock Market
- Equities
- SAGE Stock
- News Sage Therapeutics, Inc.
- Sage Therapeutics Q4 Net Loss Narrows, Net Product Revenue Declines